Favorable Industry Prospects for BDX Per a reportby Grand View Research, the global intraosseous infusion devices market size was valued at $920.3 million in 2023 and is expected to grow at a CAGR ...

Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our Growth Investor model based on the published strategy ...

Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library ...